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ABSTRACT 133 
 134 
Consistent failure over the past decades to reduce the high prevalence of stress-135 
related disorders has motivated a search for alternative research strategies. Resilience 136 
refers to the phenomenon that many people maintain mental health despite exposure 137 
to psychological or physical adversity. Instead of aiming to understand the 138 
pathophysiology of stress-related disorders, resilience research focuses on protective 139 
mechanisms that shield people against the development of such disorders and tries to 140 
exploit its insights to improve treatment and, in particular, disease prevention. To 141 
fully harness the potential of resilience research, a critical appraisal of the current 142 
state of the art – in terms of basic concepts and key methods - is needed. We 143 
highlight challenges to resilience research and make concrete conceptual and 144 
methodological proposals to improve resilience research. Most importantly, we 145 
propose to focus research on the dynamic processes of successful adaptation to 146 
stressors, in prospective longitudinal studies.  147 
 148 
 149 
 150 
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MAIN TEXT 152 
 153 
Each year, more than half a billion people around the globe suffer from a mental 154 
disorder such as anxiety, post-traumatic stress disorder (PTSD), depression, or 155 
addiction that can to some extent be traced back to the influence of exogenous or 156 
endogenous stressors. Such stressors include traumatic events, challenging life 157 
circumstances or life transitions, or physical illness (1). Together, stress-related 158 
disorders in the broadest sense annually cause a hundred million years lived with 159 
disability (YLD). In 2013, major depression was the second leading cause of 160 
disability world-wide, while anxiety disorders ranked 9th (1). Not only do these 161 
numbers imply much individual suffering; they also indicate tremendous negative 162 
consequences for society. In Europe, for instance, the direct and indirect economic 163 
costs incurred by stress-related conditions have been estimated to be over €200 164 
billion per year (2).  165 
The high incidence of stress-related disorders is not new, and a worrying aspect of 166 
the epidemiological findings is that there has, on average, been no relevant decrease 167 
in numbers over the past decades (1). This is despite huge efforts spent on 168 
investigating the pathophysiology of these disorders and despite remarkable 169 
successes that have been made in understanding disease mechanisms and in 170 
developing effective treatments. A recent survey that attempted to identify reasons 171 
for the failure to reduce disease prevalence found that the lack of improvement can 172 
neither be attributed to an increase in risk factors, i.e., stressors, nor to greater public 173 
awareness of mental disorders or greater willingness to disclose (3). More likely 174 
reasons are that the provided treatments frequently do not meet minimal quality 175 
criteria (“quality gap”) and that there are virtually no attempts to prevent disorders 176 
(“prevention gap”). In the four English-speaking countries included in the study, 177 
resources allocated to prevention and prevention research were found to be very 178 
small, and prevention efforts were somewhat provocatively characterized by the 179 
authors as “piecemeal” (3).  180 
 181 
Resilience research as an alternative strategy to promote mental health 182 
We here argue that resilience research is a promising strategy to help close the 183 
prevention gap and thereby to complement traditional disorder-focused research. The 184 
science of resilience is based on the well-documented observation that many people 185 
maintain mental health despite exposure to severe psychological or physical 186 
adversity - a pattern that has been observed across different populations and types of 187 
adversities (4–6). Resilience research aims to understand why some people do not, or 188 
only temporarily, develop stress-related mental dysfunction, in spite of being subject 189 
to the same kind of challenges that cause long-term dysfunction in other people. This 190 
approach is naturally linked to the question of how to prevent stress-related 191 
disorders, rather than attempting to treat them at a later stage when significant 192 
individual suffering and societal and economic costs have already occurred (7). 193 
Resilience research, thus, is effectively a paradigm shift away from disease-focused 194 
towards health-focused research and from investigating pathophysiology towards 195 
investigating the mechanisms that can protect individuals against stress-related 196 
disease.  197 
We therefore posit that resilience research is an important, or even necessary, 198 
complement to traditional pathophysiological research and has great potential for 199 
improving public health. We have reason to believe that this view is shared by many 200 
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in the mental health community: a Pubmed search with key words “resilience” and 201 
(“stress” or “trauma”) yields 76 entries for the year 2005 and 675 entries for 2015. In 202 
the same time period, the number of publications on “stress” or “trauma” did not 203 
even double (68% increase). 204 
In this critical time when resilience research is surging and is about to establish itself 205 
as a new paradigm, some essential questions arise: How can we now shape and 206 
inform resilience research to make sure it will tangibly improve mental health 207 
science and practice? What can we do, at this stage, to put resilience research on the 208 
right track and to optimize the potential of this new line of research and also to avoid 209 
some of the pitfalls that have hampered the progress of disease-oriented research?  210 
 211 
Challenges to contemporary resilience research 212 
A careful analysis of the results obtained to date and the methods currently used in 213 
resilience research (e.g., 8; 9) leads us to three key issues with significant bearing on 214 
future research. First, there is enormous heterogeneity in the way resilience is 215 
defined, operationalized, and measured and in the way resilience studies are 216 
designed. Therefore, when different researchers talk about resilience, they often use 217 
quite diverse concepts and their results are difficult to compare (9; 10). For example, 218 
the American Psychological Association on its website defines resilience as “the 219 
process of adapting well in the face of adversity, trauma, tragedy, threats or 220 
significant sources of stress” (www.apa.org/helpcenter/road-resilience.aspx). By 221 
contrast, some researchers consider resilience to be an ability or capacity, such as the 222 
”ability to bounce back from negative emotional experiences” (11)  or the “capacity 223 
to maintain competent functioning in the face of major life stressors“ (12). There is 224 
also the idea that resilience is a collection of various abilities and capacities (e.g., 225 
“the skills, abilities, knowledge, and insight that accumulate over time as people 226 
struggle to surmount adversity and meet challenges”; 13). While the latter definition 227 
suggests that the individual properties that define resilience may vary over time, a 228 
very popular trait-oriented perspective assumes that resilience is a fixed individual 229 
characteristic or predisposition (summarized in 14). As such, resilience is often 230 
juxtaposed to ”vulnerability” or “risk” in articles [320 hits in a Pubmed search with 231 
key words (“resilience [title]” and “vulnerability [title]”) or (“resilience [title]” and 232 
“risk [title]”) in February 2017]. One recent review concluded that “except for the 233 
main idea of facing challenges, it is somewhat difficult to guess that all of those 234 
definitions concern the same subject.” (15).  235 
Second, it has been pointed out that predictors of resilient outcomes that have been 236 
identified so far are mostly weak, usually explaining only a small proportion of the 237 
variance in long-term mental health in stressor- or trauma-exposed study populations 238 
(4; 8; 9). In this vein, it is also still unclear whether combining multiple independent 239 
predictors will improve prediction, and the replicability of predictors across various 240 
populations still has to be evaluated much more extensively (4; 8; 9). Together, this 241 
means that it is currently impossible to say with any certainty whether an individual 242 
or a group of similar individuals will show no or only temporary impairments in 243 
mental health during and after stressor exposure. We will come back to this issue 244 
later.  245 
And third, there is still a major gap between current resilience theory and the way 246 
empirical resilience research is often conducted. This last issue is of fundamental 247 
importance, and addressing it properly holds the key for finding a solution for the 248 
other issues. 249 
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 250 
An operational definition of resilience 251 
Since the seminal debate between proponents and critics of the resilience concept in 252 
the 1990’s (summarized in 16), it is widely accepted among theorists that the 253 
maintenance or quick recovery of mental health during and after exposure to 254 
significant stressors (or also other positive outcomes such as academic success or 255 
social competence, which are of particular importance for resilience research in 256 
children and adolescents) results from a dynamic process of adaptation to the given 257 
stressful life circumstances (Proposal 1) (see also Table 1). Evidence for the process 258 
nature of resilience stems from a multitude of observations showing that individuals 259 
change while they successfully cope with stressors, whether this manifests at the 260 
level of altered perspectives on life (17–19), as emergence of new strengths or 261 
competences (16), as partial immunization against the effects of future stressors (20; 262 
21), or even as epigenetic alterations and modified gene expression patterns (22; 23). 263 
In a remarkable homology, recent studies in animal models have been able to 264 
describe adaptive changes in the neural systems affected by stressor exposure 265 
specifically in animals that recovered well from stressor-induced behavioral 266 
dysfunctions; these studies also demonstrated the causal nature of these neural 267 
adaptations in recovery (24–27). To summarize, most resilience theorists currently 268 
agree that resilience is not simply inertia, or insensitivity to stressors, or merely a 269 
passive response to adversity, but the result of active, dynamic adaptation (28). 270 
The process nature of resilience implies that resilience is not a trait or stable 271 
personality profile, or a specific genotype or some hard-wired feature of brain 272 
architecture (Proposal 2). Such predispositions may well contribute to positive 273 
adaptation, just as some other predispositions may make a person vulnerable to the 274 
effects of stressors. But taking seriously the insights gained by resilience theorists in 275 
the last decades means that it does not make much sense to equate resilience with a 276 
score on a resilience questionnaire or some value derived from a gene or blood test or 277 
a brain scan or any other one-time (cross-sectional) measure that is applied before 278 
adversity has occurred. In other words, resilience is not simply the flip-side of 279 
vulnerability. If, by contrast, resilience is increasingly being understood as the 280 
outcome of a dynamic process of successful adaptation to adversity, then, logically, 281 
resilience should operationally be defined “ex post facto”, that is as a good mental 282 
health outcome following an adverse life event or a period of difficult life 283 
circumstances (29) (Proposal 3). In this logic, resilience cannot be measured in the 284 
absence of adversity, but only in response to stressful circumstances or potentially 285 
traumatizing events. Stable, trait-like characteristics or predispositions - which we 286 
term “resilience factors” - may make resilient responding to a stressor more likely, 287 
just as predispositions to vulnerability make resilient responding less likely; but they 288 
do so by facilitating the activation of intra-individual coping mechanisms or 289 
promoting beneficial interactions with the environment. Hence, resilience processes 290 
are distinct from resilience factors in that they always go along with neural, and often 291 
also behavioral activity, such as when someone uses his/her good cognitive emotion 292 
regulation capacity (a likely resilience factor) to actually exert emotion regulation in 293 
a stressful situation; or when someone’s stress hormone release is limited through the 294 
action of some molecular negative feedback mechanism (the existence of a 295 
functional feedback system being another example of a hypothetical resilience 296 
factor); or when someone solves a social conflict or successfully seeks help by 297 
exploiting his/her good communication abilities (communication ability being yet 298 
another potential resilience factor). Another type of active resilience process is when 299 
experiences of adversity lead to an improvement or optimization of skills, capacities, 300 
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or behaviors, e.g., when someone is forced by new challenges to develop new 301 
emotion regulation strategies, making it likelier he/she will show optimized stress 302 
responses the next time he/she is challenged (9). Importantly, these dynamic 303 
processes or mechanisms themselves not only depend on a person’s personality, or 304 
genotype, or brain architecture, but very much also on the nature of the stressor(s) 305 
and the complex and time-varying constellations of intra-, inter- and extra-individual 306 
circumstances present during and after stressor exposure. Hence, to be able to 307 
discover and understand resilience mechanisms (in the sense of the critical processes 308 
of successful adaptation), empirical resilience research must move from a static to a 309 
dynamic and process-oriented conceptualization. This has important consequences 310 
for study design.  311 
 312 
Consequences for study design 313 
Contemporary resilience studies still often consider resilience as a score on one of 314 
the many available resilience questionnaires and correlate such scores with some 315 
other variable (e.g., personality, genotype, brain structure) in a cross-sectional 316 
design. The conclusion drawn from these studies is often that one has discovered the 317 
“resilient personality” or a “resilience gene” etc. This strategy implies either that 318 
resilience is a stable characteristic or predisposition (counter to our Proposal 2) or, 319 
alternatively, that resilient outcomes following adversity can be predicted by these 320 
questionnaires and, thus, the questionnaires can be used as surrogate markers for 321 
resilient outcomes that would otherwise have to be determined in tedious prospective 322 
studies. The latter assumption is also problematic because, if resilience results from a 323 
dynamic process of adaptation (see our Proposal 1), then it is relatively unlikely that 324 
a single baseline measure can satisfactorily predict a resilient outcome. Indeed, none 325 
of the current resilience questionnaires has been empirically validated as a good 326 
predictor of positive mental health outcomes following adversity in prospective 327 
studies (30). Other potential predictors such as specific personality properties usually 328 
only explain a few percent in outcome variance (8) and are not strong enough for 329 
individual prediction.  330 
For these reasons, we would like to emphasize that, currently, there are no one-time 331 
(cross-sectional) resilience measures or surrogate or biomarkers of resilience and 332 
that, at the present state, there is a pressing need for more prospective longitudinal 333 
studies on resilience (Proposal 4). A prospective resilience study should consist of, 334 
ideally, a baseline assessment of the relevant outcome dimension (e.g., some mental 335 
health measure, or also any other index of psychosocial functioning relevant to the 336 
study population) before stressor exposure (T1) and, necessarily, an endpoint 337 
assessment of the outcome dimension, which should happen at a reasonable temporal 338 
distance from the offset of stressor exposure (T2) (9). In this simplest possible 339 
scenario, resilience can be operationalized as stable or only moderately deteriorated 340 
mental health (more generally, psychological function) despite stressor exposure. 341 
Stressor exposure itself has to be measured and quantified with as much detail as 342 
possible, because – evidently – moderate functional deterioration in somebody with 343 
massive stressor exposure is a more resilient outcome than moderate functional 344 
deterioration in somebody with only moderate stressor exposure. Hence, changes in 345 
mental health from T1 to T2 must be considered in relation to the adversity an 346 
individual has encountered (10). Such kinds of prospective studies may eventually 347 
identify valid outcome predictors - perhaps from patterns across multimodal data - 348 
that can then be used as surrogate markers in cross-sectional studies. However, 349 
measures of resilience based on longitudinal assessment are currently indispensable. 350 
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Beyond these minimum requirements for longitudinal resilience studies, a gold 351 
standard in study design that would permit researchers to even better align empirical 352 
resilience research with resilience theory involves measuring mental health/function 353 
at several time points during and after stressor exposure. Multiple sampling points 354 
allow for the delineation of trajectories of healthy responding that have already been 355 
shown in many different populations to range from stable mental health profiles with 356 
only small temporary disturbances (“minimal-impact resilience”) to profiles of initial 357 
dysfunction followed by rapid recovery (“emergent resilience”) (4; 8). Such careful 358 
phenotyping with high temporal resolution is a necessary basis for describing the 359 
presumably time-varying, individually variable and interactive engagement of the 360 
social, psychological and biological resilience processes (mechanisms) that generate 361 
the phenotypes. The monitoring of these mechanisms, then, should ideally also 362 
proceed with repeated measurements at high temporal resolution, as should the 363 
monitoring of stressor exposure. (Note that trajectory studies have so far mostly been 364 
conducted at time scales ranging from many months to a few years but will use much 365 
higher sampling frequencies in the future, owing to the possibilities of modern 366 
information technologies. However, even with much higher sampling rates, changes 367 
in mental health/function scores will still have to be present for at least a few weeks 368 
to be considered meaningful, i.e., not simply reflecting situational variation or noise. 369 
Meaningful changes in resilience mechanisms and stressor exposure, on the other 370 
hand, may as well occur on a much shorter time scale.) 371 
Prospective studies conducted along these lines will in most cases come to include 372 
subjects that will experience different stressors at different times over the course of 373 
participation and will react with very different changes in mental health. Most study 374 
populations will thus contain more or less stressor-naïve as well as stressor-exposed 375 
subjects, allowing for comparisons akin to the comparisons between trauma-exposed 376 
and non-trauma-exposed subjects in traditional retrospective studies (e.g., in the field 377 
of PTSD research). In the same vein, these studies will permit comparisons between 378 
subjects with resilient and non-resilient (pathological) outcomes (e.g., absence or 379 
presence of a PTSD or depression diagnosis). Beyond these traditional – often binary 380 
- categorizations, the more fine-grained resolution of stressor exposure and mental 381 
health monitoring will, however, also permit statistical assessments based on 382 
continuous variables as well as the application of advanced modeling methods 383 
exploiting individual temporal dynamics to understand the dynamic and causal 384 
interactions between the included variables. Such process analyses will elucidate 385 
both pathological but notably also beneficial (resilient) adaptations. 386 
A review of prospective resilience studies with a focus on outcome prediction 387 
To critically evaluate our claim that the current state of research does not permit 388 
conceptualization of resilience as a trait or predisposition, we reviewed the available 389 
prospective studies that attempted to identify baseline (T1) predictors of resilient 390 
outcome after stressor exposure (T2 or later). If studies that operationalize resilience 391 
in the way we here endorse show evidence for baseline factors that strongly and 392 
robustly predict mental health after adversity, this would substantially weaken our 393 
claim. To the contrary, it would suggest that resilience can to some extent be 394 
measured in the absence of adversity (e.g., by simply using a questionnaire or some 395 
behavioral or biological test at a single time point). Such surrogate measures or 396 
biomarkers could then replace the quantification of resilience in tedious and 397 
expensive prospective-longitudinal studies.  398 
Consequently, we included only studies in our review in which subjects’ mental 399 
health or psychological functioning was assessed at least once before a period of 400 
stressor exposure (baseline) and at least once after such a period (follow-up), in a 401 
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quantitative way. Because we were interested in identifying potential predictors of 402 
maintained or quickly recovering mental health despite adversity, we were not 403 
interested in studies where the baseline assessment involved only well-established 404 
predictors of mental health problems, such as pre-existing mental health problems or 405 
a life history of previous stressor exposure. Next, we did not consider studies where 406 
the amount or degree of stressor exposure between baseline and follow-up(s) was not 407 
well quantified. As argued above, stressor quantification is necessary to be able to 408 
test whether observed individual differences in stressor-induced mental health 409 
changes may simply be a consequence of individual differences in stressor exposure, 410 
which would be trivial. Hence, studies that simply reported a disease diagnosis (e.g., 411 
myocardial infarction or cancer) without a further qualification of the severity or 412 
duration of the disease were excluded, as were studies where a difficult life phase 413 
(e.g., war zone deployment, stressful professional training) was not further 414 
characterized in terms of the severity or number of specific events or challenges with 415 
which it was associated. In addition, where stressor exposure was quantified, it had 416 
to show a positive relationship to the development of mental health problems. 417 
Studies where this was not the case were excluded, as it was not clear in those studies 418 
whether the stressor(s) to which subjects were exposed were responsible for the 419 
reported mental health impairments. We also restricted our review to studies in 420 
adolescents and adults, to avoid the complications related to the very dynamic 421 
trajectories of change in children, which make outcome predictions particularly 422 
difficult. Finally, studies had to have group sizes of at least 30 subjects. 423 
Among the remaining studies, one additional key criterion emerged. This can best be 424 
illustrated by two studies finding in different cohorts of soldiers that were assessed 425 
for post-traumatic symptoms both before and after war zone deployment that pre-426 
deployment (baseline) military unit cohesion – an indicator of social support by 427 
comrades - negatively predicted post-deployment (follow-up) post-traumatic 428 
symptoms (31; 32). This suggests that unit cohesion, or more generally, social 429 
support, is a predictor of good mental health, which is a relevant and interesting 430 
finding. However, when taking into consideration a quantitative measure of 431 
deployment-related stressor exposure (combat exposure scale) by asking whether the 432 
interaction between unit cohesion and stressor exposure predicted post-deployment 433 
post-traumatic symptoms, there was no significant effect in either study (31: personal 434 
communication). In other words, pre-deployment unit cohesion in these studies did 435 
not moderate the effects of stressor exposure on post-traumatic symptoms. This, 436 
however, is the critical test when trying to answer the question whether a given 437 
baseline factor protects individuals against mental health deterioration in the face of 438 
adversity. Therefore, for the purpose of our review, it was not sufficient if a study 439 
merely corrected for effects of stressor exposure by using it as a covariate, and we 440 
only included studies that calculated predictor by stressor exposure interactions. 441 
From those studies, we only report the resulting moderation effects. Thereby, we 442 
ensured to only discuss resilience predictors, as opposed to global mental health 443 
predictors. An alternative strategy to take into consideration stressor exposure that 444 
was employed by some studies was to match a sample with stressor-related mental 445 
health impairments to a control sample with comparable stressor exposure but 446 
without corresponding mental health problems. 447 
Table 2 shows all thirteen selected studies. Four reported null effects. Three studies 448 
expressed predictor effect sizes in terms of the proportion of variance in the follow-449 
up outcome measure explained by the predictor. Percentages ranged between 5 and 450 
13 (for trait self-enhancement, hair cortisol concentration, cortisol stress reactivity, 451 
and expression of specific gene networks). The maximum group size in these three 452 
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studies was 94, suggesting the results should be regarded as preliminary. Two studies 453 
expressed effect sizes in terms of odds ratios (ORs), which were in the small to very 454 
small range (0.82 – 7.5, for number of glucocorticoids in blood cells, perceived 455 
general health, and male gender). The lower ORs (0.82 and 1.46) were reported in a 456 
study with 2172 participants, whereas the comparatively high OR of 7.5 was reported 457 
in a study with only 68 participants, suggesting it should also be classified as 458 
preliminary. Four other studies did not quantify effect sizes. One identified resilience 459 
predictor, male gender (OR=1.46), was not significant in the four other studies in 460 
which it was tested. None of the other identified predictors has so far been tested for 461 
replication.  462 
Overall, this literature review shows that the pattern of the potential resilience 463 
predictors identified so far is still very diverse and that there is no indication that any 464 
of the investigated predictors could be reasonably used as a surrogate marker for 465 
resilience, let alone be equated with resilience. That is, there is currently no empirical 466 
support for the popular idea that resilience is a predisposition. If anything, the 467 
existing data suggest that there may be multiple separate predisposing factors 468 
(“resilience factors” in our terminology), each of which has a small effect on 469 
outcomes. We conclude that it is clearly necessary to conduct more prospective 470 
resilience studies, a) to be able to better evaluate the predictive value of multiple 471 
baseline resilience factors, and b) to be able to address processes of adaptation 472 
occurring during and after stressor exposure, which is the focus of our 473 
recommendations. Note that this conclusion must be seen in the light of the 474 
limitations associated with our non-systematic review method, involving a lack of 475 
comprehensive searching and no formal quality assessment over and above the 476 
criteria explained above. 477 
A final remark worth making is that any of the potential resilience factors listed in 478 
Table 2 could as well be framed as risk factors, by simply inverting their direction. 479 
For example, while high trait self-enhancement might be considered a resilience 480 
factor, one could as well call low self-enhancement a risk factor. This shows that 481 
research that only focuses on outcome predictors has little to add to traditional 482 
vulnerability research. Resilience research can make an original contribution to 483 
mental health science only where it investigates the dynamics of stressor adjustment. 484 
 485 
An invitation 486 
Trying to align empirical research with theory in the field of resilience based on our 487 
Proposals 1 (process nature of resilience) and 2 (resilience is not a trait) has 488 
important practical consequences for how resilience is to be measured (Proposal 3: 489 
ex post facto) and for how studies are to be designed (Proposal 4: prospective). 490 
Notably, our operational definition of resilience as stable or only temporarily 491 
disturbed mental health despite adversity is not based on a single specific theory 492 
about what the crucial resilience mechanisms are and therefore does not presuppose 493 
the processes or mechanisms that produce the resilient outcome. It is much more 494 
open to scientific discovery than the mechanistic definitions most resilience 495 
questionnaires are based on (30), and it allows researchers from different theoretical 496 
schools to find a common basis and to compare their results. This will ultimately 497 
reduce much of the heterogeneity and confusion in the field and also reduce 498 
misperceptions in the interpretation of results by the public. It may well be that – as 499 
resilience research advances – our operational definition can be replaced by a 500 
definition of resilience that explicitly names specific predispositions, mechanisms 501 
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and interactive processes. We therefore only consider our approach a temporary, 502 
pragmatic solution that provides a suitable tool to advance research in the field. 503 
By proposing that resilience be defined and studied based on outcomes in 504 
prospective studies, we do not want to argue against the search for resilience 505 
predictors or surrogate markers. As long as these are not confounded with resilience 506 
itself, improved predictors will help in the discovery of psychological or biological 507 
resilience mechanisms and can one day be useful in clinical decision-making. 508 
However, we strongly warn against terminology such as “resilience genes” or 509 
epigenetic “resilience mark(er)s” or neural “resilience networks” that promise more 510 
than they can deliver. In the era of large-scale genomics and hypothesis-free big 511 
biodata collection, we believe there is a big danger in an oversimplified use of the 512 
term resilience that will ultimately damage the field and prevent it from making the 513 
contribution to the science of mental health that we believe it can make. 514 
We admit that the proposed approach, while surely more viable and promising than 515 
cross-sectional approaches, implies that we need to conduct resilience studies that are 516 
inevitably much more expensive, time-consuming and laborious. We are also aware 517 
that resilience research faces the special challenge that exposure to significant life 518 
stressors is rarely predictable and may be limited, even in high-risk cohorts such as 519 
deployed soldiers or other service members, and that base rates of maladaptive (non-520 
resilient) outcomes can also be surprisingly low (4–6). If the majority of subjects in a 521 
study are either not heavily exposed or do not develop mental health problems, this 522 
obviously makes statistical analysis difficult. This problem is even bigger when the 523 
goal is to study cohorts that are representative for the general population, making 524 
large-scale multi-center studies indispensable. Hence, 21st century resilience research 525 
will be resource-demanding and challenging and can only be accomplished in an 526 
international collaborative effort, to which we herewith invite our colleagues. We are 527 
convinced that these efforts will eventually pay off by reducing mental suffering and 528 
the many other burdens associated with stress-related disease. 529 
 530 
  531 
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TABLES 642 
 643 
 644 
Proposal 1 The maintenance or quick recovery of mental health during and after 
exposure to significant stressors results from a dynamic process of 
adaptation to the given stressful life circumstances. 
Proposal 2 Resilience is not a trait or stable personality profile, or a specific genotype or 
some hard-wired feature of brain architecture. Resilience should not be 
understood as a predisposition and, thus, is not the flip-side of vulnerability. 
We refer to stable resilience-conducive traits or other predispositions as 
“resilience factors“. 
Proposal 3 Resilience should operationally be defined “ex post facto”, that is as a good 
mental health outcome following an adverse life event or a period of difficult 
life circumstances. 
Proposal 4 At present, there is a pressing need for prospective longitudinal resilience 
studies. 
Table 1. Proposals for future resilience research. 645 
  646 
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 647 
First author, 
year 
Study 
population 
Type of 
stressor 
Main outcome 
(d=dichotomous, 
c=continuous) 
Significant 
baseline outcome 
predictors (positive 
results) 
Non-significant 
baseline outcome 
predictors (negative 
results)* 
Breen, 2015 
(23) 
Male 
marines 
(N=47 vs. 
47; and 24 
vs. 24) 
War zone 
deployment 
PTSD onset (d); 
post-traumatic 
stress 
symptoms (c) 
Expression of gene 
network related to 
innate immune 
responses§ (EV=10-
13%) 
 
 
Clark, 2013 
(33) 
Male 
soldiers 
(N=253) 
War zone 
deployment, 
previous 
trauma 
Post-traumatic 
stress 
symptoms (c) 
COMT genotype  
Eraly, 2014 
(34) 
Male 
marines 
(N=1719) 
War zone 
deployment 
Post-traumatic 
stress 
symptoms (c) 
- C-reactive protein 
(CRP) plasma levels 
Gupta, 2010 
(35) 
College 
students 
(N=69) 
Potentially 
traumatic 
events 
Distress (c) Trait self-
enhancement 
(EV=8%) 
Gender, social 
desirability, trait 
general optimism, 
trait neuroticism 
Jenness, 
2016 (36) 
Adolescents 
(N=78) 
Intense 
terror attack 
media 
coverage 
Post-traumatic 
stress 
symptoms (c) 
Trait reappraisal, 
trait 
catastrophizing§ 
Age, gender, trait 
rumination, trait 
problem solving 
Kline, 2013 
(31) 
Soldiers 
(N=918) 
War zone 
deployment 
Post-traumatic 
stress 
symptoms (c) 
- 
 
Gender, unit 
cohesion&, 
preparedness& 
 
 
McAndrew, 
2016 (32) 
Soldiers 
(N=286; 
N=335) 
War zone 
deployment 
General mental 
health problems 
(c) 
- Unit cohesion, non-
avoidant coping 
Morin, 2017 
(37) 
Old-aged 
adults 
(N=1395) 
Health 
events 
(cancer, 
stroke, heart 
disease, 
lung 
disease) 
Depressive 
symptoms (c) 
- Age, gender, financial 
assets, education 
Smid, 2015 
(38) 
Male 
soldiers 
(N=433) 
Post-war 
zone 
deployment 
stressful life 
events 
Post-traumatic 
stress 
symptoms (c) 
T cell cytokine 
production§ , innate 
cytokine production§ 
T cell-induced 
chemokines/IL-6 
Steudte-
Schmiedgen, 
2015 (39) 
Male 
soldiers 
(N=90; 
N=80) 
War zone 
deployment 
Post-traumatic 
stress 
symptoms (c) 
Hair cortisol 
concentration 
(EV=10%), cortisol 
stress reactivity 
(EV=5%) 
Pre-deployment 
traumatic events, 
childhood trauma 
Van Zuiden, 
2011 (40) 
Male 
soldiers 
(N=34 vs. 
34) 
War zone 
deployment 
PTSD onset (d) Number of 
glucocorticoid 
receptors (GRs) in 
blood cells§ 
(OR=7.5) 
mRNA expression of 
GR genes, GILZ, 
SGK-1, FKBP5; 
plasma cortisol 
Wald,  2013 
(41) 
Male 
soldiers 
(N=1085) 
War zone 
deployment 
Post-traumatic 
stress 
symptoms (c) 
Attentional threat 
bias$, 5-HTTLPR 
genotype$, their 
interaction 
 
Zhu, 2014 
(42) 
Older adults 
(N=2172) 
Onset of 
moderate to 
severe pain 
Depressive 
symptoms (c) 
Perceived health 
(OR=0.82), male 
gender (OR=1.46) 
Age, chronic illness 
*predictors that were tested but were not significant 648 
§risk factor, i.e., predicting symptom worsening 649 
&personal communication 650 
$direction of effect depending on bias X genotype interaction term 651 
PTSD, post-traumatic stress disorder; EV, explained variance; OR, odds ratio 652 
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Table 2. Studies investigating baseline predictors of resilient outcome after stressor 653 
exposure. 654 
